Document is current

Any future updates will be listed below

The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial

Crossref DOI link: https://doi.org/10.1007/s10157-015-1086-2

Published Online: 2015-02-07

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark